ACD440 Gel in Peripheral Neuropathic Pain

Summary

This is a double-blind, randomized, placebo-controlled crossover outpatient study in patients with peripheral neuropathic pain with allodynia or hyperalgesia to cold, heat, brush and/ or pinprick stimulation. Patients will in random order receive ACD440 Gel or placebo treatment twice daily for 7 days, topically applied to the painful area. This is followed by a 2-week washout period, then receive the alternate treatment.

Timeline

Start

2022-06-20

Primary completion

2023-03-10

Completion

2023-03-10

Drugs

Indications